Revenue | ₹1,702.60Cr |
Net Profits | ₹138.42Cr |
Net Profit Margins | 8.13% |
Alembic Pharmaceuticals Ltd’s revenue jumped 4.23% since last year same period to ₹1,702.60Cr in the Q3 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 1.44% jump in its revenue since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit fell -23.29% since last year same period to ₹138.42Cr in the Q3 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -9.77% fall in its net profits since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit margin fell -26.41% since last year same period to 8.13% in the Q3 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -11.05% fall in its net profit margins since last 3-months.
The revenue for Alembic Pharmaceuticals Ltd in the Q3 results 2024 was ₹1,702.60Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q3 results 2024 was ₹138.42Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q3 results 2024 was 8.13%.
The revenue for Alembic Pharmaceuticals Ltd in the Q3 results 2023 was ₹1,633.46Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q3 results 2023 was ₹180.45Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q3 results 2023 was 11.05%.